当前位置: 首页 > 期刊 > 《医学信息》 > 2018年第12期
编号:13311141
右美托咪定替代瑞芬太尼对甲状腺手术全麻患者术后恶心呕吐的影响(4)
http://www.100md.com 2018年3月26日 《医学信息》 2018年第12期
     [9]张红,严祥,冷玉芳.右美托咪定镇痛作用的临床研究进展[J].国际麻醉学与复苏杂志,2017,38(6):550-553.

    [10]陈明慧,俞红丽,常涛,等.右美托咪定用于预防腹腔镜胆囊切除术后恶心呕吐的效果[J].临床麻醉学杂志,2017,33(3):261-263.

    [11]Bakri MH,Ismail EA,Ibrahim A.Comparison of dexmedetomidine and dexamethasone for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy [J].Korean J Anesthesiol,2015,68(3):254-260.

    [12]Liang X,Zhou M,Feng JJ,et al.Efficacy of dexmedetomidine on postoperative nausea and vomiting:a met-analysis of randomized controlled trial[J].Int J Clin Exp Med,2015,8(6):8450-8471.

    [13]Geng ZY,Liu YF,Wang SS,et al.Intra-operative dexmedetomidine reduces early postoperative nausea but not vomiting in adult patients after gynaecological laparoscopic surgery:A randomised controlled trial[J].European Journal of Anaesthesiology,2016,33(10):761.

    [14]Lim H,Doo AR,Son JS,et al.Effects of intraoperative single bolus fentanyl administration and remifentanil infusion on postoperative nausea and vomiting[J].Korean J Anesthesiol,2016,69(1):51-56.

    收稿日期:2018-3-18;修回日期:2018-4-17

    編辑/李桦, 百拇医药(程燕 张宁 郭金光)
上一页1 2 3 4